Date 20/nov/2024 01:23PM Unit Bio Ref Interval: Laboratory Investigation Report

Laboratory Investigation Report
Patient Name : Mr. Subir Das Centre : 1103 - Max Hospital Saket(East Block)
Age/Gender : 70 Y 3 M 27 D /M OP/IP No/UHID : OP/SKCR548604/
MaxID/Lab ID : SKDD.975081/0832112420812 Collection Date/Time : 20/Nov/2024 01:23PM
Ref Doctor : Dr.Nikhil Agrawal Reporting Date/Time : 20/Nov/2024 02:22PM
Clinical Biochemistry
SIN No:DD0521152
LDH (Lactate Dehydrogenase) Total , Serum
Date 20/Nov/2024 Unit Bio Ref Interval
01:23PM
LDH 160 IU/L 0 - 248
Lactate to pyruvate
Lipid Profile,Serum
Date 21/Nov/2024 17/May/24 Unit Bio Ref Interval
08:55AM 08:05AM
Cholesterol 238 198 mg/dL 0 - 200
Cholesterol oxidase, esterage,
peroxidase
HDL Cholesterol 50 43 mg/dL > 40
Direct measure immunoinhibition
LDL Cholesterol 132 119 mg/dL 0 - 100
Direct measure
Triglyceride 235.0 140.0 mg/dL 0 - 150
Enzymatic end point
VLDL Cholesterol 47.0 28.0 mg/dl < 30
Calculated
Total Cholesterol/HDL Ratio 4.8 4.6 .. 0.0-4.9
Calculated
Non-HDL Cholesterol 188.00 155.00 mg/dL < 130
Calculated
HDL/LDL 0.38 0.36 Ratio 0.3 - 0.4
Calculated
Interpretation
Optimal: < 100 mg/dL

Near Optimal/ Above Optimal: 100-
Desirable: < 200 mg/dL
129
Borderline High: 200-239
Total mg/dL
mg/dL LDL-C
Cholesterol Borderline High: 130-159 mg/dL
High ≥ 240 mg/dL
High: 160-189 mg/dL
Very High: ≥ 190 mg/dL
Normal: <150 mg/dL

Low HDL: < 40 mg/dL Borderline High: 150-199 mg/dL
HDL-C Triglyceride
High HDL: ≥ 60 mg/dL High: 200-499 mg/dL
Very High: ≥ 500 mg/dL
Page 1 of 13
Test Performed at :910 - Max Hospital - Saket M S S H, Press Enclave Road, Mandir Marg, Saket, New Delhi, Delhi 110017
Booking Centre :1103 - Max Hospital Saket(East Block), 1, 2, Press Enclave Marg, Saket Institutional Area, Saket, New Delhi, 7982100200
The authenticity of the report can be verified by scanning the Q R Code on top of the page
SIN No:DD0521152
Total Iron Binding Capacity (TIBC), Serum

Date 20/Nov/2024 20/Nov/23 Unit Bio Ref Interval
01:23PM 04:16PM
Iron 82 108 µg/ dL 70-180
TPTZ NO DEPROTEINIZATION
UIBC 211 155 µg/ dL 155-355
Nitroso PSAP
Total Iron Binding Capacity 293 263 µg/ dL 225-535
Calculated
Transferrin Saturation 27.99 41.06 % 17-37
Calculated
HbA1c (Glycated/ Glycosylated Hemoglobin) Test

HPLC

01:23PM 08:05AM
Glycosylated 5.34 5.52 % < 5.7
Haemoglobin(Hb A1c)
Glycosylated 34.85 36.82 mmol/mol < 39.0
Haemoglobin(Hb A1c) IFCC
Average Glucose Value For 106.56 111.72 mg/dL
the Last 3 Months
Average Glucose Value For 5.90 6.19 mmol/L
the Last 3 Months IFCC
Interpretation The following HbA1c ranges recommended by the American Diabetes Assocation(ADA) may be used as an aid in the diagnosis of diabetes
mellitus.
HbA1C(NGSP %) HbA1C(IFCC mmol/mol) Suggested Diagnosis

> 6.5 > 48 Diabetic
5.7 - 6.4 39 - 47 Pre- Diabetic
< 5.7 < 39 Non - Diabetic
HbA1C provides a useful index of average glycaemia over the preceding 6-8 weeks.
It is suggested that HbA1c is measured every 6 months in stable patients, every 3 months in patients with unstable metabolic control and every month in pregnancy.
Increased Glycated hemoglobin is a reflection of Hyperglycemia.
Page 2 of 13
SIN No:DD0521152
Liver Function Test (LFT), Serum
Date 20/Nov/2024 17/May/24 20/Nov/23 Unit Bio Ref Interval
01:23PM 08:05AM 04:16PM
Total Protein 7.80 7.30 7.80 g/dL 6.6 - 8.3
Biuret, reagent blank, end point
Albumin 4.6 4.2 4.5 g/dL 3.2 - 4.6
Bromocresol Green (BCG)
Globulin 3.2 3.1 3.3 g/dL 2.3 - 3.5
Calculated
A.G. ratio 1.4 1.4 1.4 1.2 - 1.5
Calculated
Bilirubin (Total) 0.50 0.70 0.60 mg/dL 0.3 - 1.2
DPD
Bilirubin (Direct) 0.08 0.19 0.09 mg/dL 0 - 0.2
Diazotization
Bilirubin (Indirect) 0.42 0.51 0.51 mg/dL 0.1 - 1.0
Calculated
SGOT- Aspartate 19 46 17 U/L 0 - 50
Transaminase (AST)
UV without P5P
SGPT- Alanine 16 86 16 U/L 13 - 40
Transaminase (ALT)
UV without P5P
AST/ALT Ratio 1.19 0.53 1.06 Ratio
Calculated
Alkaline Phosphatase 70 81 78 U/L 30 - 120
PNPP, AMP Buffer
GGTP (Gamma GT), Serum 20.0 28.0 18.0 U/L < 55
G-glutamyl Carboxy nitroanilide
Kindly correlate with clinical findings

*** End Of Report ***
Page 3 of 13
Hematology
SIN No:DD0521152
CBC (Complete Blood Count), Whole Blood EDTA
01:23PM 04:16PM
Haemoglobin 14.6 13.5 g/dl 13.0 - 17.0
Packed Cell, Volume 42.4 40.4 % 40-50
Calculated
Total Leucocyte Count (TLC) 7.2 6.9 10~9/L 4.0-10.0
Electrical Impedance
RBC Count 4.21 4.11 10~12/L 4.5-5.5
MCV 100.8 98.3 fL 83-101
MCH 34.8 32.8 pg 27-32
Calculated
MCHC 34.5 33.4 g/dl 31.5-34.5
Calculated
Platelet Count 152 208 10~9/L 150-410
MPV 11.5 9.6 fl 7.8-11.2
Calculated
RDW 14.2 13.1 % 11.5-14.5
Calculated
Differential Cell Count

VCS / Light Microscopy
Neutrophils 62.1 62.1 % 40-80

Lymphocytes 29.6 30.6 % 20-40
Monocytes 5.8 6.0 % 2-10
Eosinophils 1.9 1.0 % 1-6
Basophils 0.6 0.3 % 0-2
Absolute Leukocyte Count

Calculated from TLC & DLC
Absolute Neutrophil Count 4.47 4.28 10~9/L 2.0-7.0

Absolute Lymphocyte Count 2.1 2.1 10~9/L 1.0-3.0
Absolute Monocyte Count 0.42 0.41 10~9/L 0.2-1.0
Absolute Eosinophil Count 0.14 0.07 10~9/L 0.02-0.5
Absolute Basophil Count 0.040 0.020 10~9/L 0.02-0.1

Page 4 of 13
Hematology
SIN No:DD0521152
Page 5 of 13
Immunoassay
SIN No:DD0521152
Vitamin B12 & Folate, Serum
Date 20/Nov/2024 Unit Bio Ref
01:23PM Interval
Vitamin B12 74.00 pg/mL 120 - 914
Chemiluminescence
Folate Serum 18.0 ng/mL >5.9
CLIA
Comment
Reference Group for Folate in ng/ml:
Normal Range: (> 5.9)
Indeterminate Range: (4.0 - 5.9)
Deficient Range: (< 4.0)
Note:- Vitamin B12 (Cobalamin)

Vitamin B12 is tested for patients with GIT disease, Neurological disease, psychiatric disturbances, malnutrition, alcohol abuse.
Increased in chronic renal failure, severe CHF.
Decreased in megaloblastic anemia.
Advise: CBC, peripheral smear, serum folate levels, intrinsic factor antibodies (IFA), bone marrow examination, if Vit B12 deficient.
Folate :-
A folate deficiency can lead to megaloblastic anemia and ultimately to severe neurological problems. Folate deficiency can be caused
by insufficient dietary intake, malabsorption or excessive folate utilization, which is common during pregnancy, alcoholism, hepatitis,
or other liver-damaging diseases.
Ferritin, Serum
01:23PM 01:22PM 04:16PM
Ferritin 503.74 637.19 1084.74 ng/mL 23.9 - 336.2
CLIA
Comment Ferritin is a large hollow spherical protein containing iron, concentration of which roughly reflects the body iron content in many individuals. Serum
ferritin concentration is a sensitive indicator of iron deficiency. Serum Ferritin concentration is increased in many disorders like infection, inflammatory disorders like
rheumatoid arthritis or renal disease; common liver conditions (e.g. alcoholism, viral hepatitis B or C); heart disease, cancer. In patients with these disorders who also
have iron deficiency their serum ferritin concentrations are often normal. An increase in serum ferritin concentration occurs as a result of ferritin release due to liver cell
injury of diverse causes. Serum ferritin is also increased in patients with iron overload of any cause. Serum transferrin saturation is a better screening test for early iron
overload than serum ferritin.
Page 6 of 13
Immunoassay
SIN No:DD0521152
Thyroid Profile ( Free T3, Free T4 & TSH)

Date 20/Nov/2024 17/May/24 Unit Bio Ref
01:23PM 01:38PM Interval
Free Triiodothyronine (FT3) 3.20 2.59 pg/mL 2.6 - 4.2
CLIA
Free Thyroxine (FT4) 0.69 0.73 ng/dL 0.58 - 1.64
CLIA
Thyroid Stimulating 3.15 3.53 µIU/mL 0.38 - 5.33
Hormone
CLIA
Comment
Premature Cord Blood
Upto 2 1st 2nd 3rd
Parameter Unit (28 - 36 (> 37
Month Trimester Trimester Trimester
weeks) weeks)
FT3 Pg/mL 0.15 - 3.91 2.4 - 5.6 2.11 - 3.83 1.96 - 3.38 1.96 - 3.38
FT4 ng/dl 1.7 - 4.0 0.7- 2.0 0.5 - 1.6 0.5 - 1.6
TSH uIU/ml 0.7 - 27.0 2.3 - 13.2 0.5 - 10 0.05 - 3.7 0.31 - 4.35 0.41 - 5.18
Note : TSH levels are subject to circadian variation, reaching peak levels between 2 – 4 am
and at a minimum between 6 – 10 pm. The variation is of the order of 50% - 206 %, hence
time of the day has influence on the measured serum TSH concentrations.
Comment: TSH - Ultrasensitive
CEA (Carcino Embryonic Antigen),Serum

01:23PM 08:05AM 04:16PM
CEA 2.18 3.02 1.41 ng/ml 0-3
CLIA
Page 7 of 13
Immunoassay
SIN No:DD0521152
Vitamin D, 25 - Hydroxy Test (Vit. D3), Serum

01:23PM 01:38PM
25 Hydroxy, Vitamin D 20.91 20.28 ng/mL 30-100
CLIA
Ref Range
25 (OH) Vitamin D Concentration Range
Vitamin D Status
(ng/ml)
Sufficiency 30-100
Insufficiency 20-29
Deficiency <20
Potential Toxicity
>100
Interpretation
Vitamin D toxicity can be due to
1. Use of high doses of vitamin D for prophylaxis or treatment
2. Taking vitamin D supplements with existing health problems such as kidney disease, liver disease , tuberculosis and hyperparathyroidism
Vitamin D deficiency can be due to:
1. Inadequate exposure to sunlight,
2. Diet deficient in vitamin D
3. Malabsorption
Advice: Serum calcium, phosphorus and PTH

Page 8 of 13
SIN No:DD0521152
Renal Profile,Serum + Urine
Urea, Serum
01:23PM 04:16PM
Urea 22.7 30.4 mg/dL 17 - 43
Urase, UV
B.U.N (Blood Urea Nitrogen), Serum

01:23PM 04:16PM
Blood Urea Nitrogen 10.6 14.2 mg/dL 7.9 - 20
Calculated
Comment Serum urea nitrogen is increased in Intra vascular volume depletion, diuretics, CCF, GI bleeding, tetracycline intake and renal failure.
Reduced levels are seen in chronic liver disease and alcohol abuse.
Page 9 of 13
SIN No:DD0521152
Creatinine, Serum
01:23PM 04:16PM
Creatinine 1.3 1.3 mg/dL 0.8 - 1.3
Alkaline picrate kinetic
eGFR by MDRD 54.52 54.68 ml/min/1.73
MDRD m²
eGFR by CKD EPI 2021 58.57 58.93
Ref. Range
eGFR - Estimated Glomerular Filteration Rate is calculated by MDRD equation which is most accurate for GFRs ≤ 60ml / min
/1.73 m².MDRD equation is used for adult population only.
Category Ref Interval (ml / min / 1.73 m² ) Condition
Normal or High
G1 ≥90
G2 60 - 89 Mildly Decreased
G3a 45 - 59 Mildly to Moderately Decreased
G3b 30 - 44 Moderately to Severly Decreased
G4 15 - 29 Severly Decreased
G5 < 15 Kidney failure
Sodium, Serum
01:23PM 04:16PM
Sodium 139.0 136.0 mmol/L 136 - 146
ISE Indirect
Page 10 of 13
SIN No:DD0521152
Potassium, Serum
01:23PM 04:16PM
Potassium 4.50 4.69 mmol/L 3.5 - 5.1
ISE Indirect
Chloride, Serum
01:23PM 04:16PM
Chloride 103 102 mmol/L 101 - 109
ISE Indirect
Bicarbonate, Serum
01:23PM 04:16PM
Bicarbonate 30.0 25.0 mmol/L 22 - 29
Colorimetric, PEPC
Calcium, Serum
01:23PM 04:16PM
Calcium (Total) 9.6 9.6 mg/dL 8.8 - 10.2
Arsenazo III
Comment
Increased in Primary and Tertiary hyperparathyroidism, malignant disease with bone involvement, Polycythemia vera, pheochromocytoma and Sarcoidosis.
Advise: PTH testing. If normal or increased, then check urine Ca++/ Creatinine ratio to exclude Familial benign hypocalciuric hypercalcemia (FBHH)
Decreased in surgical or congenital hyperparathyroidism; Vitamin D deficiency, chronic renal failure; magnesium deficiency, prolonged anticonvulsant therapy, acute
pancreatitis, hyperphosphatemia, massive blood transfusion, leprosy, proximal and distal renal tubular disease, alcoholism and hepatic cirrhosis.
Advice: Albumin, Phosphate, Creatinine, Alkaline Phosphatase and PTH.

Page 11 of 13
Clinical Pathology
SIN No:DD0521152
Urine Routine And Microscopy

01:23PM 08:05AM 04:16PM
Microscopy
Colour Light-Yellow Yellow Pale Yellow Pale Yellow

Visual Observation/ Automated
PH 5.5 5.5 5.5 .. 5-6
Double Indicator
Specific Gravity 1.012 1.014 1.015 1.015 - 1.025
pKa change
Protein Nil + Neg Nil
Protein-error of indicators
Glucose. Nil Nil Neg Nil
Enzyme Reaction
Ketones Nil Nil Neg Nil
Acetoacetic Reaction
Blood Trace Trace Neg Nil
Benzidine Reaction
Bilirubin Nil Nil Neg Nil
Diazo Reaction
Urobilinogen Normal Normal Normal Normal
Ehrlichs Reaction
Nitrite Negative Negative Neg
Conversion of Nitrate
Microscopy
Red Blood Cells (RBC) Occasional Occasional 0 /HPF Nil

Light Microscopy/Image capture
microscopy
White Blood Cells 1-2 1-2 1 /HPF 0.0-5.0
microscopy
Squamous Epithelial Cells 0-1 0-1 1 /HPF
microscopy
Cast Nil Nil Nil /LPF Nil
microscopy
Crystals Nil Nil Nil .. Nil
microscopy
Bacteria Nil Nil Nil /HPF Nil
Page 12 of 13
Clinical Pathology
SIN No:DD0521152

microscopy

Page 13 of 13
Patient Name : Mr.Subir Das Centre : 1103 - Max Hospital Saket(East Block)
Age/Gender : 70 Y 3 M 27 D /M OP/IP No/Max ID/Mobile : OP/SKCR548604//
MaxID/Lab ID : SKDD.975081//0832112420812 Collection Date/Time : 20/Nov/2024 01:23PM
Ref Doctor : Nikhil Agrawal Reporting Date/Time : 21/Nov/2024 12:24PM
Microbiology
SIN No:DD0521152
Urine Culture & Sensitivity

Method : Semi quantitative-Culture/ID & Sensitivity by Vitek 2
Result No growth.
Interpretation. Sterile after Overnight/24 hours of aerobic incubation at 37 degree C.
Comment
Urine pus
Colony count Interpretation
cells /HPF
<5 10'3 Insignificant growth, more likely to be a colonizer.
To be treated only if the patient is symptomatic
<5 10'4 Moderately significant growth. Should be correlated clinically
and to be treated only if the patient is symptomatic
10'5
<5 Significant growth. Should be treated if the patient is clinically
symptomatic
Significant growth. Should be treated if the patient is clinically

>5 10'3 / 10'4 / 10'5
symptomatic
5 - 10 No growth Kindly rule out the cause of sterile pyuria i.e Is the patient on
antibiotics Or anyother systemic illness (e.g TB /STD)
Mixed growth of more than two types of organisms indicating
>5 Mixed growth specimen colonization. Kindly send mid-stream urine sample
after proper collection.
Page 1 of 1
BookingCentreAddress :1103 - Max Hospital Saket(East Block), 1, 2, Press Enclave Marg, Saket Institutional Area, Saket, New Delhi, 7982100200

Date 20/nov/2024 01:23PM Unit Bio Ref Interval: Laboratory Investigation Report

Uploaded by

Copyright:

Available Formats

Date 20/nov/2024 01:23PM Unit Bio Ref Interval: Laboratory Investigation Report

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Date 20/nov/2024 01:23PM Unit Bio Ref Interval: Laboratory Investigation Report

Uploaded by

Copyright:

Available Formats

Laboratory Investigation Report

Optimal: < 100 mg/dL

Normal: <150 mg/dL

Total Iron Binding Capacity (TIBC), Serum

HbA1c (Glycated/ Glycosylated Hemoglobin) Test

Date 20/Nov/2024 17/May/24 Unit Bio Ref Interval

HbA1C(NGSP %) HbA1C(IFCC mmol/mol) Suggested Diagnosis

Kindly correlate with clinical findings

Differential Cell Count

Neutrophils 62.1 62.1 % 40-80

Absolute Leukocyte Count

Absolute Neutrophil Count 4.47 4.28 10~9/L 2.0-7.0

Kindly correlate with clinical findings

Note:- Vitamin B12 (Cobalamin)

Thyroid Profile ( Free T3, Free T4 & TSH)

Comment: TSH - Ultrasensitive

CEA (Carcino Embryonic Antigen),Serum

Vitamin D, 25 - Hydroxy Test (Vit. D3), Serum

Kindly correlate with clinical findings

B.U.N (Blood Urea Nitrogen), Serum

Category Ref Interval (ml / min / 1.73 m² ) Condition

Kindly correlate with clinical findings

Urine Routine And Microscopy

Colour Light-Yellow Yellow Pale Yellow Pale Yellow

Red Blood Cells (RBC) Occasional Occasional 0 /HPF Nil

Light Microscopy/Image capture

Kindly correlate with clinical findings

Urine Culture & Sensitivity

Significant growth. Should be treated if the patient is clinically

Kindly correlate with clinical findings

*** End Of Report ***

You might also like

* End Of Report *